| Name | Title | Contact Details |
|---|---|---|
Dan Masciopinto |
Chief Technology Officer | Profile |
Skilled nursing home providing rehabilitation, long term care, and specialized dementia care in St. James, NY
CleanCut Technologies is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Affinity Health Plan is an independent, not-for-profit organization offering low cost, quality health care coverage to underserved New Yorkers. Its programs are sponsored by New York State and include Child Health Plus, Family Health Plus, Medicaid managed care, and Medicare. Founded in 1986, Affinity serves more than 275,000 members in New York City, Long Island, and the surrounding counties of Westchester, Rockland and Orange.
We empower greater health. Today, we have access to highly personalized and useful information in almost every area of our lives; our money, transportation, food, exercise, entertainment, and home security yet we don’t have this same access to the data and insights contained in our personal health records. The current healthcare system is highly complex and constrains the flow of useful information; patient health data and medical records are stored in hundreds of different systems, across thousands of independent organizations in millions of different formats. We simplify this complexity to securely connect healthcare decision-makers to the clinical data and hidden insights contained in patent medical records so that they can deliver greater outcomes at lower costs.
SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.